Patent ID: 6074645
Filing Date: 2000-06-13
Classification: A01K,A61K,A61P,C07K,C12N,G01N

Abstract:
A vaccine against human cytomegalovirus which elicits an MHC Class I cellular immune response to human cytomeaglovirus comprising a peptide selected from the group consisting of NX.sub.1 VPMVATX.sub.2, wherein X.sub.1 is L, I, M, T, or V and X.sub.2 is V, A, C, I, L or T (SEQ ID NO: 2) with the proviso that the peptide is not NLVPMVATV (SEQ ID NO:1); YXEHPTFSQY, wherein X is S, T or L (SEQ ID NO: 4); FX.sub.1 FPKDVALX.sub.2, wherein X.sub.1 is V or T and X.sub.2 is L, R, or K (SEQ ID NO: 6); and TPRVTGGGAX, wherein X is L, M, or F (SEQ ID NO: 8); and (SEQ ID NO: 9).